Faeth Therapeutics (4070) Q2 2026 Earnings Report
DE:4070 Q2 2026 EPS Results
- Actual EPS
- -EUR 2.54
- Consensus EPS
- -EUR 2.36
- Beat/Miss
- Missed by -EUR 0.18
- One Year Ago EPS
- -EUR 3.50
DE:4070 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/04/2026
- Time
- Before Open
- Conference Call
- Tuesday, August 4, 2026
DE:4070 Upcoming Earnings
Faeth Therapeutics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4070 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -0.69- | -3.24 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -2.36-2.54 | -3.5 | 27.37% (+0.96) | |
| May 15, 2026 | 2026 (Q1) | -0.55-117.53 | -4.83 | -2334.26% (-112.70) | |
| Mar 30, 2026 | 2025 (Q4) | -4.30-3.39 | -5.54 | 38.87% (+2.15) | |
| Nov 14, 2025 | 2025 (Q3) | -3.67-3.24 | -5.19 | 37.59% (+1.95) | |
| Aug 05, 2025 | 2025 (Q2) | -5.01-3.50 | -5.01 | 30.18% (+1.51) | |
| May 06, 2025 | 2025 (Q1) | -3.99-4.83 | -5.72 | 15.63% (+0.89) | |
| Mar 28, 2025 | 2024 (Q4) | -5.07-5.54 | -5.36 | -3.33% (-0.18) | |
| Nov 14, 2024 | 2024 (Q3) | -5.58-5.19 | -5.01 | -3.57% (-0.18) | |
| Aug 06, 2024 | 2024 (Q2) | -5.16-5.01 | -5.54 | 9.68% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
